
HCGMCC Unveils Blood Test Capable of Detecting 30 Cancers with 98% Accuracy
Health Tech
The study, conducted on 6,445 participants, including 2,831 untreated cancer patients across all stages,…
Health Tech
The study, conducted on 6,445 participants, including 2,831 untreated cancer patients across all stages,…
Venture Capital
Inside the capital-efficient startup using real-world patient data to train AI tools for healthcare…
Venture Capital
From Venture Capital Darling To Cautionary Tale Glossier has regressed from cult status to…
Venture Capital
Madison Reed is rolling out an agentic-AI concierge to boost bookings and product discovery—on…
Venture Capital
Coinbase sold itself as the “secure and trusted” face of crypto. In reality, it…
Venture Capital
As GLP-1 drugs like Ozempic boom, ShapeScale’s 3D body scanner claims DXA-level accuracy—revealing whether…
Venture Capital
Finance runs on spreadsheets. OPCO.AI thinks that’s a $1 trillion risk. Wall Street’s next…
Venture Capital
Wall Street, Madison Avenue, and SoHo already give NYC unmatched density. With ILPN, the…
Venture Capital
Longevity investing isn’t dead—it’s evolving into a new era. In my previous article on…
Venture Capital
South Asian weddings aren’t just celebrations—they’re an economic force. With multi-day events averaging $150,000…
Venture Capital
With 250 biomarkers and a $5M raise, Kean wants to prove predictive health isn’t…
Venture Capital
For two decades, retailers poured billions into personalization engines and homepages. The result? Bloated…
Venture Capital
The rideshare boom reshaped urban transportation, bringing millions of riders and drivers into a…